Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.69 |
| ▸ | NLN | Q9BYT8 | 3/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6957266 | 0.87 | CYP3A4 (0.69) | CYP3A4SLC7A5NLN | |
| SCHEMBL13331622 | 0.87 | CYP3A4 (0.69) | CYP3A4SLC7A5NLN | |
| SCHEMBL18162790 | 0.87 | CYP3A4 (0.69) | CYP3A4SLC7A5NLN | |
| SCHEMBL27450330 | 0.86 | CYP3A4 (0.67) | CYP3A4SLC7A5NLN | |
| SCHEMBL27913326 | 0.84 | CYP3A4 (0.69) | CYP3A4SLC7A5NLN | |
| SCHEMBL27895551 | 0.83 | CYP3A4 (0.73) | CYP3A4SLC7A5NLN | |
| SCHEMBL12259752 | 0.83 | CYP3A4 (0.63) | CYP3A4SLC7A5NLN | |
| SCHEMBL19227330 | 0.83 | CYP3A4 (0.63) | CYP3A4SLC7A5NLN | |
| Water SCHEMBL27996282 | 0.82 | CYP3A4 (0.71) | CYP3A4SLC7A5NLN | |
| SCHEMBL18862447 | 0.82 | CYP3A4 (0.61) | CYP3A4SLC7A5NLN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184926-A | Amino acid functionalized chiral covalent organic framework material and preparation and application thereof | 周口师范学院 | 2024-06-14 | — | — | CN | claimed |
| CN-113512877-B | Continuous production process for silver metal firmly attached aromatic special fiber filament | 铜陵蔚屹新材料有限公司 | 2022-05-03 | — | — | CN | claimed |
| CN-122088620-A | Multi-agent distributed situation interaction device and method based on multi-mode large model | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260102740-A1 | Electrodialysis Systems and Methods | UNIV YALE (US) | 2026-04-16 | — | — | US | disclosed |
| US-20250379290-A1 | NITROGEN BATTERY, FUEL SYNTHESIS APPARATUS, AND FUEL SYNTHESIS METHOD | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2025-12-11 | — | — | US | disclosed |
| CN-119900102-A | Fiber capable of being used for ocean pasture | 九州星际科技有限公司 | 2025-04-29 | — | — | CN | disclosed |
| WO-2025084328-A1 | AMMONIA PRODUCTION APPARATUS | 出光興産株式会社 | 2025-04-24 | — | — | WO | disclosed |
| WO-2025084329-A1 | AMMONIA PRODUCTION DEVICE | 出光興産株式会社 | 2025-04-24 | — | — | WO | disclosed |
| CN-119855790-A | Production of hydrogen and lithium hydroxide in alkaline environments | 赢创运营有限公司 | 2025-04-18 | — | — | CN | disclosed |
| WO-2025041619-A1 | APPARATUS FOR PRODUCING LITHIUM METAL AND METHOD FOR PRODUCING LITHIUM METAL | 株式会社豊田中央研究所 | 2025-02-27 | — | — | WO | disclosed |
| US-12237473-B2 | Secondary battery | MURATA MANUFACTURING CO., LTD. (JP) | 2025-02-25 | — | — | US | disclosed |
| EP-4043559-A1 | IMPROVED URICASE AND METHOD FOR TREATING HYPERURICEMIA USING SAME | Shanghai Junshi Biosciences Co., Ltd. (CN) | 2022-08-17 | — | — | EP | disclosed |
| CN-114767707-A | Composition for preventing or treating coronavirus infection diseases comprising low molecular chitosan | 艾美科健株式会社 | 2022-07-22 | — | — | CN | disclosed |
| CN-114517410-A | Antibacterial and antistatic yarn and preparation method and application thereof | 吴江市新三养纺织有限公司 | 2022-05-20 | — | — | CN | disclosed |
| CN-114502728-A | Improved uricase and methods for its use in treating hyperuricemia | 上海君实生物医药科技股份有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-113512877-B | Continuous production process for silver metal firmly attached aromatic special fiber filament | 铜陵蔚屹新材料有限公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-114349057-A | Preparation method of electrode material, electrode and supercapacitor | 深圳大学 | 2022-04-15 | — | — | CN | disclosed |
| WO-2022018710-A1 | MONOLITHIC PROTECTED LITHIUM CASSETTE ANODE | PRABAHARAN SAVARI RATHINAM SAHAYA (IN) | 2022-01-27 | — | — | WO | disclosed |
| CN-103442735-B | Active principle for undesirable medical condition in mitigation technique field | 特米拉公司 | 2016-11-09 | — | — | CN | disclosed |
| CN-103442735-A | Effective element for alleviating undesired medical conditions in the technical field | BOWDEN TIM | 2013-12-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102740-A1 | Electrodialysis Systems and Methods | SLC9A2, SLC8A1, SLC9A3 | CYP3A4 3447/4885SLC7A5 333/4885NLN 3055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.